ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Protocols Approved By NCI During January 2004

February 27, 2004

In Brief: Hawaii Study finds No Increase Risk for Large Bowell Cancer From High Intake Of Saturated Fat

October 12, 1984

House Bill Provides 5.7% Increase To NIH, But Passage Threatened By Amendments

August 4, 1995

Panel Urges New Research Consortium For Stomach, Esophageal Cancers

January 17, 2003

NCI awards $7.3 Million for Studies In Cancer communications

October 15, 1993

Ultmann Appeals For Better Funding, Cancer Act Renewal

June 28, 1985